Potential new mRNA-based therapy for pre-eclampsia

Lipid nanoparticles targeting VEGF mRNA show promise in treating pre-eclampsia, restoring maternal blood pressure and enhancing fetal health in murine models.

Memo Therapeutics raises $27.67m for kidney transplant infection trial – Pharmaceutical Technology

BK virus, a member of the polyomavirus family, can reactivate in patients post-transplant due to the immunosuppressive drug regimen. Image credit: Shutterstock/Kateryna Kon. Switzerland-headquartered Memo

November 2, 2023

Antimicrobial resistance prevalence tied to patient age and sex

A person’s age and sex are correlated with the chance that they have a bloodstream infection caused by a bacterium that is resistant to antibiotics,

March 15, 2024

Precision livestock technologies offer earlier diagnosis of calf-killing bovine respiratory disease

Monitoring dairy calves with precision technologies based on the “internet of things,” or IoT, leads to the earlier diagnosis of calf-killing bovine respiratory disease, according

July 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.